Knowing the results of psychedelics on human brain networks is important to unlocking their therapeutic mechanisms. In individuals, during the approximately six hour length of action, psilocybin raises glutamate signalling and glucose metabolism19,twenty,21, broadly decreases the strength of electrophysiological signals22, cuts down hemodynamic f